|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.72 CNY | -0.45% |
|
+0.72% | -26.94% |
| Capitalization | 9.65B 1.33B 1.26B 1.17B 1.04B 1.88B 113B 2.06B 14.49B 5.35B 46.27B 4.99B 4.88B 201B | P/E ratio 2022 |
-34.3x | P/E ratio 2023 | 150x |
|---|---|---|---|---|---|
| Enterprise value | 9.69B 1.33B 1.26B 1.17B 1.04B 1.88B 113B 2.06B 14.54B 5.37B 46.43B 5.01B 4.9B 201B | EV / Sales 2022 |
13.9x | EV / Sales 2023 | 10.3x |
| Free-Float |
80.69% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
| 1 day | -0.45% | ||
| 1 week | +0.72% | ||
| Current month | +2.18% | ||
| 1 month | -6.41% | ||
| 3 months | +17.03% | ||
| 6 months | -10.85% | ||
| Current year | -26.94% |
1 week
19.38
20.20
1 month
18.4221.75
Current year
15.8627.65
1 year
15.8631.19
3 years
15.8646.94
5 years
11.4854.04
10 years
11.4854.04
| Director | Title | Age | Since |
|---|---|---|---|
Jun Bo Wang
DFI | Director of Finance/CFO | 40 | 2022-02-27 |
Li Qiao
IRC | Investor Relations Contact | 41 | 2023-01-17 |
Yun Tang
SEC | Corporate Secretary | 52 | 2020-09-07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xuan Min Zhao
BRD | Director/Board Member | 69 | 2020-01-14 |
Bo Yang
CHM | Chairman | 50 | 2023-01-17 |
Zhan Lu Ji
BRD | Director/Board Member | 43 | 2020-09-10 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.45% | +0.72% | -31.81% | -44.28% | 1.33B | ||
| -0.14% | -1.37% | +14.45% | +29.00% | 5.08B | ||
| -0.47% | -2.59% | -32.00% | +1.62% | 3.9B | ||
| -0.82% | -1.97% | -8.32% | +3.59% | 2.97B | ||
| -1.25% | -2.68% | -8.64% | +19.99% | 2.91B | ||
| -0.70% | -0.12% | -3.41% | -9.44% | 2.49B | ||
| -0.71% | +0.24% | -3.89% | -3.00% | 1.74B | ||
| -2.79% | -2.39% | +29.91% | +60.82% | 1.68B | ||
| -0.71% | -2.65% | -4.24% | -17.51% | 1.63B | ||
| -2.14% | -3.96% | +67.51% | +103.20% | 1.56B | ||
| Average | -1.02% | -1.58% | +1.96% | +14.40% | 2.53B | |
| Weighted average by Cap. | -0.85% | -1.54% | -0.40% | +14.60% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 995M 137M 129M 120M 107M 193M 11.62B 212M 1.49B 551M 4.77B 514M 503M 20.68B | 1.28B 177M 167M 155M 138M 250M 15B 274M 1.93B 711M 6.15B 664M 649M 26.7B |
| Net income | -399M -54.89M -51.89M -48.13M -42.92M -77.52M -4.66B -84.93M -598M -221M -1.91B -206M -202M -8.29B | 90.08M 12.4M 11.72M 10.87M 9.7M 17.51M 1.05B 19.19M 135M 49.91M 432M 46.57M 45.55M 1.87B |
| Net Debt | 187M 25.68M 24.27M 22.52M 20.08M 36.27M 2.18B 39.73M 280M 103M 894M 96.44M 94.33M 3.88B | 32.6M 4.49M 4.24M 3.94M 3.51M 6.34M 381M 6.94M 48.92M 18.06M 156M 16.85M 16.48M 678M |
More financial data
* Estimated data
Employees
1,811
Sector
Pharmaceuticals
Calendar
2025-04-28
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-09 | 19.72 ¥ | -0.45% | 5,091,783 |
| 24-12-06 | 19.81 ¥ | +1.75% | 7,534,958 |
| 24-12-05 | 19.47 ¥ | 0.00% | 5,457,320 |
| 24-12-04 | 19.47 ¥ | -1.86% | 8,241,685 |
| 24-12-03 | 19.84 ¥ | +1.33% | 8,652,287 |
End-of-day quote Shanghai S.E., December 08, 2024
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600771 Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition